Hyalex Orthopaedics earned FDA 510(k) clearance for its Slalom MTP hemiarthroplasty implant, according to an April 21 news release.
The implant is designed around the proprietary Hydrosurf materials platform and is for the treatment of degenerative conditions affecting the first metatarsophalangeal joint. The Slalom device restores joint function while preserving bone and soft tissue.
Hyalex plans to launch the system in a limited U.S. market release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
